SPENCER MEIER: Open Payments
NPI 1306103148 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,251 in 224 payments from 24 companies in 2025. Trend: 2023 $5,547 · 2024 $5,564 · 2025 $7,251
Food & beverage: $4,917Consulting: $1,760Speaker / faculty: $390Education: $183
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $1,590 |
| ABBVIE INC. | 18 | $1,293 |
| UCB, Inc. | 18 | $721 |
| Janssen Biotech, Inc. | 26 | $579 |
| Arcutis Biotherapeutics, Inc. | 30 | $559 |
| LEO Pharma Inc. | 11 | $339 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $331 |
| Regeneron Healthcare Solutions, Inc. | 11 | $236 |
| Galderma Laboratories, L.P. | 11 | $231 |
| Organon LLC | 11 | $221 |
Products named: CIBINQO, RINVOQ, Bimzelx, TREMFYA, Zoryve, DUPIXENT, VTAMA, SKYRIZI.
Industry payments across NV — which companies pay providers there.
